HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 3,580.00
-5.00 (-0.14%)
At close: Nov 13, 2026
HYUNDAI BIOLAND Market Cap
HYUNDAI BIOLAND has a market cap or net worth of 107.4 billion as of November 13, 2026. It is the 26,501st most valuable company in the world and the 1,173rd biggest in South Korea. Its market cap has decreased by 18.45% in one year.
Market Cap
107.40B
Enterprise Value
87.94B
Revenue
140.70B
Global Rank
Country Rank
#1,173 South Korea
PE Ratio
8.06
ChartMarket Cap Chart
Since March 1, 2002, HYUNDAI BIOLAND's market cap has increased from 25.40B to 107.40B, an increase of 322.78%. That is a compound annual growth rate of 6.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 107.40B | -16.65% |
| Dec 30, 2025 | 128.85B | -4.87% |
| Dec 30, 2024 | 135.45B | -9.52% |
| Dec 28, 2023 | 149.70B | -25.80% |
| Dec 29, 2022 | 201.75B | -21.80% |
| Dec 30, 2021 | 258.00B | -29.65% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NOVAREX | 151.38B |
| Kyung Dong Pharmaceutical | 144.45B |
| PHARMARESEARCH BIO | 117.48B |
| Ahn-Gook Pharmaceutical | 106.83B |
| OPTUS Pharmaceutical | 105.35B |
| High Tech Pharm | 96.66B |
| DongKoo Bio & Pharma | 91.81B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 88.83B |